Lv4
420 积分 2025-05-01 加入
Comparative effectiveness and safety of upadacitinib, abrocitinib and dupilumab in treatment-resistant prurigo nodularis
2个月前
已完结
Long-term dupilumab treatment for chronic refractory generalized prurigo nodularis: A retrospective cohort study
2个月前
已完结
Dupilumab treatment for prurigo nodularis: a retrospective study of 76 patients
2个月前
已关闭
Dupilumab: an Additional Arrow in the Quiver for Prurigo Nodularis? Data From a Real-Life Setting
2个月前
已关闭
Evaluating the Clinical Meaning of Dermatology Life Quality Index Scores Between Different Phenotypes of Atopic Dermatitis in Patients Before and After Biologic Therapy With Dupilumab
2个月前
已完结
Comparative effectiveness and safety of upadacitinib, abrocitinib and dupilumab in treatment-resistant prurigo nodularis
2个月前
已完结
Effectiveness and Safety of Dupilumab for Prurigo Nodularis in China: A Multicentric and Observational Study
2个月前
已完结
The effectiveness and safety of dupilumab in the management of refractory prurigo nodularis in 45 Chinese patients: A real‐life observational study
2个月前
已完结
Impact of BMI and quality of life on dupilumab response in chronic prurigo: A cohort study
2个月前
已完结
皖公网安备34019202002308
